Tumor-on-a-Chip Biotech: CanChips Rebuilds Cancer Drug Testing

Deep Tech Germany – AI, Robotics & Frontier Innovation by Startuprad.io™ · Dec 13, 2025 · 31m · transcript

What if the tools used to test cancer drugs don't behave like human tumors at all? That question pushed Ghazaleh Madani, CEO and co-founder of CanChips, to build tumor-on-a-chip platforms that replicate human tumor biology — one of the more compelling innovations in oncology today.

Full article, links, and sources:

Read the full episode notes on Startuprad.io

Why this matters for deep tech: Organ-on-a-chip is frontier biotech: microfluidics and human-cell engineering aimed at replacing models that mispredict drug response. CanChips is deep tech at the intersection of hardware, biology, and…